Frans F. H. Rutten

TL;DR: These estimates are considerably lower than estimates based on the traditional human capital approach, but they better reflect the economic impact of illness.

TL;DR: A general approach is discussed to assess the uncertainty surrounding the cost effectiveness ratio (C/E-ratio) estimated on the basis of data from a randomised clinical trial, which includes the calculation of a 95% probability ellipse and introduces the concept of a so called C/ E-acceptability curve.

TL;DR: The book focuses on the US literature and health care system with 24 chapters written by US authors and only 11 by European and Canadian authors, and the structure both reflects the contributions in the health economics literature and the large variation in US health care institutions.

TL;DR: This report of an ISPOR Good Practices Task Force reviews what national guidelines for economic evaluation say about transferability, discusses which elements of data could potentially vary from place to place, and recommends good research practices for dealing with aspects of transferability.

TL;DR: The contents of this book demonstrate that given efficient research teams, research funding can produce both significant new knowledge of direct relevance to the reform of health care systems world-wide, and also collaborative, mutually informative work between Europeans and others living outside the EEC.